• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Chemotherapy Market

Chemotherapy Market: by Drugs (Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics), Indication (Leukemia, Lymphoma, Breast Cancer, Ovarian Cancer), Route of Drug Administration (Oral, Intravenous), End-User (Hospitals, Research Institutes) - Global Forecast till 2025


Market Synopsis:
Chemotherapy is a type of cancer treatment which consists of the use of one or more chemotherapeutic agents including anti-cancer drugs. The treatment mainly prevents the cancer cells division and growth of cancer cells by killing the dividing cells. Moreover, it is used in the treatment of different types of cancer such as lung cancer, breast cancer, leukemia, myeloma, sarcoma, lymphoma, ovarian cancer, and others. The chemotherapy drugs can be managed directly into the bloodstream or can be targeted to exact cancer sites. However, this treatment also includes several side effects such as nausea & vomiting, alopecia, hair loss, fatigue, hearing impairment, mucositis, loss of appetite, and many more.

According to the America Cancer Society, lung cancer is estimated to be the second most common cancer in both male and female. In males, prostate cancer is more common, while in female breast cancer is more common. Additionally, about 14% of all new cancers are lung cancers. Moreover, the American Cancer Society’s evaluations for lung cancer in the United States for 2018 are:
• About 234,030 new cases of lung cancer (121,680 in men and 112,350 in women)
• About 154,050 deaths occur from lung cancer (83,550 in men and 70,500 in women)
According to the Leukemia and Lymphoma Society, around every 3 minutes, one person in the United States (US) is diagnosed with a blood cancer. Moreover, an estimated combined total of 172,910 people in the US were diagnosed with leukemia, lymphoma or myeloma in 2017.

Factors Influencing the Market Scenario:
The market is driven by several factors including growing prevalence of different types of cancers such as lung cancer, sarcoma, lymphoma, breast cancer, myeloma, and others. According to the breastcancer.org, in 2018, it is estimated that about 266,120 new cases of invasive breast cancer are expected to be diagnosed in women in the U.S., along with 63,960 new cases of non-invasive breast cancer. Additionally, it is estimated that about 2,550 new cases of invasive breast cancer are predicted to be diagnosed in men in 2018. A man’s lifetime risk of breast cancer is about 1 in 1,000.

Moreover, the technological advancements and rising emphasis on research and development in the field of oncology may propel the growth of the market. 
However, the huge cost of treatment and poor reimbursement policies in the developing regions are some of the restraining factors of the market.

Regional analysis:
Geographically, the market is split into four major regions such as North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA). The North American market is mainly driven by the growing number of market players engaged in manufacturing the chemotherapy drugs, the rising patient population, and growing healthcare expenditure. Additionally, available healthcare facilities and use of advanced technologies in cancer research and treat also drive the market in this region.

Europe also contributes to the growth of the market owing to rising government support for research and development and growing pharmaceutical companies engaged in research for the various types of cancer. Moreover, Asia Pacific is predicted to be the fastest growing region due to the growing demand for chemotherapy drugs and the accessibility of well-qualified and capable healthcare professionals such as oncologists and also due to the fastest growth of healthcare sector. The market is also growing in the Middle East & Africa due to growing awareness about various types of cancer, their diagnosis, and different availability of treatment options.
 

Key Players: 
The global chemotherapy market comprises of various major players including Sanofi, Novartis, Pfizer Inc., Eli Lilly & Company, ImClone Systems Inc., GlaxoSmithKline, AstraZeneca, Schering-Plough, Boehringer Ingelheim, Bristol-Myers Squibb, Teva Pharmaceuticals Industries, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Chemo Espana SL, CELGENE CORPORATION, Amgen Inc, Bayer AG, Takeda Pharmaceutical Company Limited, and others.
For instance, in July 2017, TESARO, Inc. and Takeda Pharmaceutical Company Limited announced an exclusive licensing agreement for the commercialization and clinical development of novel cancer therapy ‘niraparib’, in Japan.

Recent Developments:
For instance, in May 2018, it has been announced in Bhopal that cancer patients will get free chemotherapy at district hospitals. This was done under the Cancer Care Programme.
Additionally, in May 2018, Tech giant Microsoft announced a partnership with the Fred Hutchinson Cancer Research Centre to tackle chemotherapy side effects using new AI tech.
 

Chemotherapy Market Segmentation

By Drug: 
• Alkylating Agents
o Mustard Gas Derivatives
o Ethylenimines
o Alkyl Sulfonates
o Hydrazines
o Triazines
o Others
• Antimetabolites
• Anti-Tumor Antibiotics
o Anthracyclines
o Chromomycin
• Topoisomerase Inhibitors
o Topoisomerase I Inhibitors
o Topoisomerase Ii Inhibitors
• Mitotic Inhibitors
• Others

By Indication: 
• Leukemia
• Lymphoma
• Breast Cancer
• Ovarian Cancer
• Lung Cancer
• Myeloma
• Sarcoma
• Others

By Route of Drug Administration: 
• Oral
• Intravenous

By End-User: 
• Hospitals
• Research Institutes
• Others

Regions Covered:
o North America

  • U.S.
  • Canada
  • Mexico

o Europe

  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe

o Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Rest of Asia-Pacific 

o LAMEA

  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

									

	

Related Reports

2019-2024 Global Cast Saw Devices Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

HNY Research projects that the Cast Saw Devices market size will grow from XX Million USD in 2018 to XX Million USD by 2024, at an estimated CAGR of XX %. The base year considered for the study is 201 ...read more

2019-2024 Global Knee Cartilage Repair Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

HNY Research projects that the Knee Cartilage Repair market size will grow from XX Million USD in 2018 to XX Million USD by 2024, at an estimated CAGR of XX %. The base year considered for the study i ...read more

2019-2024 Global Transcatheter Embolization and Occlusion Devices Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

HNY Research projects that the Transcatheter Embolization and Occlusion Devices market size will grow from XX Million USD in 2018 to XX Million USD by 2024, at an estimated CAGR of XX %. The base year ...read more

2019-2024 Global Gynecology Devices Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

HNY Research projects that the Gynecology Devices market size will grow from XX Million USD in 2018 to XX Million USD by 2024, at an estimated CAGR of XX %. The base year considered for the study is 2 ...read more

2019-2024 Global Joint Replacement Devices Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report

HNY Research projects that the Joint Replacement Devices market size will grow from XX Million USD in 2018 to XX Million USD by 2024, at an estimated CAGR of XX %. The base year considered for the stu ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.